HealthFDA scientists opposed Trump administration plan to ease access to peptides
Most FDA scientific staff opposed a Trump administration plan to make unproven peptide drugs more accessible in the United States. The drugs are favored by Health Secretary Robert F. Kennedy Jr.
People in this report Donald Trump
FDA scientists opposed Trump administration plan to ease access to peptides
